Stefan Lohmer

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA.

Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.

Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States.

Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning.

GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA.

Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

Part of Biocell Center SpA, Biocell Center Corp. is an American company that carries out research and development activities on fetal stem cells from amniotic fluid and chorionic villi. The company is located in the US. The company is the world leader in fetal stem cell banking, offering cryopreservation services. In collaboration with their partner, Bin Project, they have created a network of companies focused on the development of a biocompatible scaffold for bone regeneration.

Fondazione Toscana Life Sciences is a non-profit organization founded by and composed of public and private institutions. These institutions encompass banks, universities, provincial, municipal and educational entities. The organization was founded in 2004 and is headquartered in Sienna, Italy.

Part of IMAX Corp., IMAX Discovery GmbH develops novel and natural flavor compounds for the food and beverage industry. The company is based in Dortmund, Germany. The CEO of the German company is Alessandro Sidoli.

Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy.

Primm SRL engages in the manufacturing, marketing and sale of biotech services. It offers poly and monoclonal antibodies, peptides, DNA synthesis, DNA sequencing, protein analysis, gene cloning, recombinant protein and pharmacological and toxicological services. The firm provides research and development activities which focuses on the design, synthesis, and pharmaceutical development of bioactive peptides for therapeutical applications. The company was founded by Sidoli Alessandro in 1990 and is based in Milan, Italy.

Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy.

Bausch & Lomb-IOM SpA engages in the distribution and wholesale of contact lenses and accessories. The company was founded in 1972 and is headquartered in Vimodrone, Italy.

Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.